Skip to Content

Olanzapine Injection

Last Updated: July 7, 2017
Status: Current

Olanzapine Injection

Products Affected - Description

Olanzapine intramuscular injection, Sandoz
10 mg, vial, 1 count (NDC 00781-3159-72)

Reason for the Shortage

Sandoz did not provide a reason for the shortage of olanzapine intramuscular injection.

Available Products

Zyprexa intramuscular injection, Lilly USA, LLC
10 mg, vial, 1 count (NDC 00002-7597-01)

Olanzapine intramuscular injection, American Regent
10 mg, vial, 1 count (NDC 00517-0955-01)

Estimated Resupply Dates

Sandoz has olanzapine 10 mg vials on back order and the company estimates a release date of mid-July 2017.

Related Shortages

Aripiprazole Oral Disintegrating Tablets	Resolved
Aripiprazole Oral Solution	Resolved
Aripiprazole Short-Acting Intramuscular Injection	No Longer Available

Updated

July 7, June 22 and 6, March 28, 2017, University of Utah, Drug Information Service. Copyright 2017, Drug Information Service, University of Utah, Salt Lake City, UT.

FDA Consumer Updates

More FDA updates

Recently Approved

Tremfya Tremfya (guselkumab) is an interleukin-23 blocker indicated for the treatment of moderate-to-severe...
Endari Endari (L-glutamine) is orally-administered pharmaceutical grade L-glutamine (PGLG), an amino acid...
Triptodur Triptodur (triptorelin) is a gonadotropin releasing hormone (GnRH) agonist indicated for the...
Bevyxxa Bevyxxa (betrixaban) is an oral, once-daily Factor Xa inhibitor anticoagulant for the...

Drugs.com provides accurate and independent information on more than 24,000 prescription drugs, over-the-counter medicines and natural products. This material is provided for educational purposes only and is not intended for medical advice, diagnosis or treatment. Data sources include Micromedex® (updated July 5th, 2017), Cerner Multum™ (updated July 13th, 2017), Wolters Kluwer™ (updated July 5th, 2017) and others. To view content sources and attributions, please refer to our editorial policy.